New group therapy for PTSD shows promise in early trial
NCT ID NCT07302334
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a type of talk therapy called metacognitive therapy (MCT) can be delivered in a group setting for people with post-traumatic stress disorder (PTSD) in regular psychiatric care. The goal is to see if it is practical and acceptable to patients, and to get early signs of whether it helps with PTSD, depression, and quality of life. About 30 adults in Sweden who have PTSD will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Affektiva, ångest och traumaprogrammet, Psykiatri Sydväst
RECRUITINGStockholm, 14157, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can six short writing sessions ease PTSD in underserved patients?
- Can a psychedelic compound help veterans and first responders with PTSD and alcohol use disorder?
- Brain scans may guide psychedelics and magnetic pulses to quell suicidal thoughts
- Can online training equip therapists to tackle PTSD and addiction?
- A prescription app takes on PTSD: can digital therapy replace the couch?
- A new talk therapy aims to tackle both insomnia and PTSD in veterans